Botanical species · safety record

Olax psittacorum

The EFSA Compendium of Botanicals holds 7 constituent measurements and 3 adverse-effect records for Olax psittacorum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Olax psittacorum (Lam.) Vahl

7Constituent measurements
3Safety records
2Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Olaxoside4
  • Alkaloids2
  • Tannins1

Plant parts

  • Aerial part of plants4
  • Bark1
  • Leaves1
  • Live plants1
  • Roots and other underground parts1

Preparations

  • Solvent extraction7

Effect types

  • Digestive2
  • Not reported1

Target tissues

  • Digestive3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
OlaxosideRoots and other underground partsSolvent extraction1 Gram/kilogramGC-FIDResolve DOI
OlaxosideLeavesSolvent extraction10 Gram/kilogramGC-FIDResolve DOI
OlaxosideBarkSolvent extraction3 Gram/kilogramGC-FIDResolve DOI
AlkaloidsAerial part of plantsSolvent extraction420 Milligram/kilogramPhytochemical screeningNo resolvable identifier
AlkaloidsAerial part of plantsSolvent extraction380 Milligram/kilogramPhytochemical screeningNo resolvable identifier
OlaxosideAerial part of plantsSolvent extractionPhytochemical screeningNo resolvable identifier
TanninsAerial part of plantsPhytochemical screeningNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestiveHouse mouse (as animal)Not reportedResolve DOI
DigestiveDigestiveHouse mouse (as animal)Not reportedResolve DOI
Not reportedDigestiveLive plantsSolvent extractionHouse mouse (as animal)Not reportedResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Forgacs, P., Buffard, G., Desconclois, J. F., Jehanno, A., Provost, J., Tiberghien, R., Touche, A. Phytochemical studies and biological activities of plants endemic of the islands of Reunion and Mauritius. Plantes Medicinales et Phytotherapie, 1981, p. 80-91.
  2. FORGACS, P., PROVOST, J. OLAXOSIDE, A SAPONIN FROM OLAX-ANDRONENSIS, OLAX-GLABRIFLORA AND OLAX-PSITTACORUM. PHYTOCHEMISTRY, 1981, vol. 20, no. 7, p. 1689-1691. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue